Mind Medicine (MindMed) Inc. Announces Proposed Public Offering
NEW YORK — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it intends to offer and sell, subjec
(Financial Post, 2025-10-29T20:11:24Z)